Literature DB >> 16177040

Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice.

Jennifer A Davis1, John R James, Steven J Siegel, Thomas J Gould.   

Abstract

The effects of acute nicotine administration (0.09 mg/kg nicotine), chronic nicotine administration (6.3 mg/kg/d nicotine for 14 d), and withdrawal from chronic nicotine administration on fear conditioning in C57BL/6 mice were examined. Mice were trained using two coterminating conditioned stimulus (30 s; 85 dB white noise)--unconditioned stimulus (2 s; 0.57 mA foot shock) pairings and tested 24 h later for contextual and cued fear conditioning. Acute nicotine administration enhanced contextual fear conditioning, chronic nicotine administration had no effect on contextual fear conditioning, and withdrawal from chronic nicotine administration impaired contextual fear conditioning. Plasma nicotine concentrations were similar after acute and chronic treatment and were within the range reported for smokers. During withdrawal, concentrations of nicotine were undetectable. An acute dose of nicotine (0.09 mg/kg) during withdrawal from chronic nicotine treatment reversed withdrawal-associated deficits in contextual fear conditioning. The results suggest that tolerance to the effects of nicotine on contextual fear conditioning develops with chronic nicotine treatment at a physiologically relevant dose, and withdrawal from this chronic nicotine treatment is associated with impairments in contextual fear conditioning. These findings provide a model of how the effects of nicotine on learning may contribute to the development and maintenance of nicotine addiction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177040      PMCID: PMC2697573          DOI: 10.1523/JNEUROSCI.2853-05.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  41 in total

Review 1.  Cue dependency of nicotine self-administration and smoking.

Authors:  A R Caggiula; E C Donny; A R White; N Chaudhri; S Booth; M A Gharib; A Hoffman; K A Perkins; A F Sved
Journal:  Pharmacol Biochem Behav       Date:  2001-12       Impact factor: 3.533

Review 2.  Addiction and the brain: the neurobiology of compulsion and its persistence.

Authors:  S E Hyman; R C Malenka
Journal:  Nat Rev Neurosci       Date:  2001-10       Impact factor: 34.870

Review 3.  Nicotinic receptor subtypes and cognitive function.

Authors:  Edward D Levin
Journal:  J Neurobiol       Date:  2002-12

4.  Common molecular and cellular substrates of addiction and memory.

Authors:  Eric J Nestler
Journal:  Neurobiol Learn Mem       Date:  2002-11       Impact factor: 2.877

5.  Behavioral analysis of CREB alphadelta mutation on a B6/129 F1 hybrid background.

Authors:  L Graves; A Dalvi; I Lucki; J A Blendy; T Abel
Journal:  Hippocampus       Date:  2002       Impact factor: 3.899

Review 6.  Neurobiology of the nicotine withdrawal syndrome.

Authors:  P J Kenny; A Markou
Journal:  Pharmacol Biochem Behav       Date:  2001-12       Impact factor: 3.533

7.  Smoking after nicotine deprivation enhances cognitive performance and decreases tobacco craving in drug abusers.

Authors:  S L Bell; R C Taylor; E G Singleton; J E Henningfield; S J Heishman
Journal:  Nicotine Tob Res       Date:  1999-03       Impact factor: 4.244

8.  Novel liquid chromatographic-tandem mass spectrometric methods using silica columns and aqueous-organic mobile phases for quantitative analysis of polar ionic analytes in biological fluids.

Authors:  W Naidong; W Shou; Y L Chen; X Jiang
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-04-25

9.  Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human alpha4beta2- and alpha4beta4-nicotinic acetylcholine receptors.

Authors:  Cynthia L Gentry; Lincoln H Wilkins; Ronald J Lukas
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

Review 10.  Nicotine addiction: insights from recent animal studies.

Authors:  A M Mathieu-Kia; S H Kellogg; E R Butelman; M J Kreek
Journal:  Psychopharmacology (Berl)       Date:  2002-05-15       Impact factor: 4.530

View more
  100 in total

1.  Chronic fluoxetine ameliorates adolescent chronic nicotine exposure-induced long-term adult deficits in trace conditioning.

Authors:  David A Connor; Thomas J Gould
Journal:  Neuropharmacology       Date:  2017-08-02       Impact factor: 5.250

2.  Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats.

Authors:  Thomas J Hopkins; Laura E Rupprecht; Matthew R Hayes; Julie A Blendy; Heath D Schmidt
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

3.  The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.

Authors:  Derek S Wilkinson; Thomas J Gould
Journal:  Behav Brain Res       Date:  2011-04-14       Impact factor: 3.332

Review 4.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

Review 5.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

6.  Nicotine Addiction and Psychiatric Disorders.

Authors:  Munir Gunes Kutlu; Vinay Parikh; Thomas J Gould
Journal:  Int Rev Neurobiol       Date:  2015-09-19       Impact factor: 3.230

Review 7.  Nicotinic modulation of hippocampal cell signaling and associated effects on learning and memory.

Authors:  Munir Gunes Kutlu; Thomas J Gould
Journal:  Physiol Behav       Date:  2015-12-11

8.  Exposure to nicotine during periadolescence or early adulthood alters aversive and physiological effects induced by ethanol.

Authors:  Jennifer A Rinker; Mary Anne Hutchison; Scott A Chen; Annika Thorsell; Markus Heilig; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2011-03-21       Impact factor: 3.533

9.  The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation.

Authors:  Thomas J Gould; George S Portugal; Jessica M André; Matthew P Tadman; Michael J Marks; Justin W Kenney; Emre Yildirim; Michael Adoff
Journal:  Neuropharmacology       Date:  2012-01-21       Impact factor: 5.250

10.  Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.

Authors:  Astrid K Stoker; Svetlana Semenova; Athina Markou
Journal:  Neuropharmacology       Date:  2008-04-08       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.